These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 25068185
1. All-trans retinoic acid and arsenic trioxide induce apoptosis and modulate intracellular concentrations of calcium in hepatocellular carcinoma cells. Wei J, Ye C, Liu F, Wang W. J Chemother; 2014 Dec; 26(6):348-52. PubMed ID: 25068185 [Abstract] [Full Text] [Related]
2. Synergistic effect of all-trans-retinoic acid and arsenic trioxide on growth inhibition and apoptosis in human hepatoma, breast cancer, and lung cancer cells in vitro. Lin LM, Li BX, Xiao JB, Lin DH, Yang BF. World J Gastroenterol; 2005 Sep 28; 11(36):5633-7. PubMed ID: 16237756 [Abstract] [Full Text] [Related]
3. Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A. Iriyama N, Yuan B, Hatta Y, Horikoshi A, Yoshino Y, Toyoda H, Aizawa S, Takeuchi J. Oncol Rep; 2012 Nov 28; 28(5):1875-82. PubMed ID: 22940758 [Abstract] [Full Text] [Related]
4. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines. Kito M, Akao Y, Ohishi N, Yagi K, Nozawa Y. Biochem Biophys Res Commun; 2002 Mar 08; 291(4):861-7. PubMed ID: 11866444 [Abstract] [Full Text] [Related]
5. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide. Jung YS, Cheong HJ, Kim SJ, Kim KH, Lee N, Park HS, Won JH. Leuk Res; 2014 Aug 08; 38(8):977-82. PubMed ID: 24953245 [Abstract] [Full Text] [Related]
6. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma. Li W, Wang M, Wang L, Ji S, Zhang J, Zhang C. Cell Biochem Biophys; 2014 Mar 08; 68(2):427-36. PubMed ID: 23975599 [Abstract] [Full Text] [Related]
7. Combination of Poly I:C and arsenic trioxide triggers apoptosis synergistically via activation of TLR3 and mitochondrial pathways in hepatocellular carcinoma cells. Shen P, Jiang T, Lu H, Han H, Luo R. Cell Biol Int; 2011 Aug 08; 35(8):803-10. PubMed ID: 21418039 [Abstract] [Full Text] [Related]
8. PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G2/M checkpoint and suppression of DNA damage repair. Luo Q, Li Y, Deng J, Zhang Z. Chem Biol Interact; 2015 Jan 25; 226():12-22. PubMed ID: 25499136 [Abstract] [Full Text] [Related]
9. Retinoic acid dramatically enhances the arsenic trioxide-induced cell cycle arrest and apoptosis in retinoic acid receptor alpha-positive human T-cell lymphotropic virus type-I-transformed cells. Darwiche N, El-Sabban M, Bazzi R, Nasr R, Al-Hashimi S, Hermine O, de Thé H, Bazarbachi A. Hematol J; 2001 Jan 25; 2(2):127-35. PubMed ID: 11424005 [Abstract] [Full Text] [Related]
10. The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells. Luo Q, Li Y, Lai Y, Zhang Z. J Toxicol Sci; 2015 Jun 25; 40(3):349-63. PubMed ID: 25972196 [Abstract] [Full Text] [Related]
11. Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo. Song J, Zhao Z, Fan X, Chen M, Cheng X, Zhang D, Wu F, Ying X, Ji J. Oncotarget; 2016 Oct 25; 7(43):70504-70515. PubMed ID: 27655700 [Abstract] [Full Text] [Related]
12. Normoxically overexpressed hypoxia inducible factor 1-alpha is involved in arsenic trioxide resistance acquisition in hepatocellular carcinoma. Tung JN, Cheng YW, Hsu CH, Liu TZ, Hsieh PY, Ting LL, Ko HL, Chang YJ, Chiou JF, Wu AT. Ann Surg Oncol; 2011 May 25; 18(5):1492-500. PubMed ID: 21181559 [Abstract] [Full Text] [Related]
13. Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells. Freitas RA, Silva dos Santos GA, Gimenes Teixeira HL, Scheucher PS, Lucena-Araujo AR, Lima AS, Abreu e Lima RS, Garcia AB, Jordão AA, Falcão RP, Vannucchi H, Rego EM. Leuk Res; 2009 Jul 25; 33(7):958-63. PubMed ID: 19013639 [Abstract] [Full Text] [Related]
14. Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB. Ma Y, Wang J, Liu L, Zhu H, Chen X, Pan S, Sun X, Jiang H. Cancer Lett; 2011 Feb 01; 301(1):75-84. PubMed ID: 21078540 [Abstract] [Full Text] [Related]
15. The impact of arsenic trioxide and all-trans retinoic acid on p53 R273H-codon mutant glioblastoma. Karsy M, Albert L, Murali R, Jhanwar-Uniyal M. Tumour Biol; 2014 May 01; 35(5):4567-80. PubMed ID: 24399651 [Abstract] [Full Text] [Related]
16. Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo. Zhao XS, Song PL, Sun B, Jiang HC, Liu TF. Hepatobiliary Pancreat Dis Int; 2009 Oct 01; 8(5):510-7. PubMed ID: 19822495 [Abstract] [Full Text] [Related]
17. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2]. Lu HQ, Zheng J. Ai Zheng; 2006 Dec 01; 25(12):1470-6. PubMed ID: 17166369 [Abstract] [Full Text] [Related]
18. Glycolytic metabolism confers resistance to combined all-trans retinoic acid and arsenic trioxide-induced apoptosis in HL60rho0 cells. Herst PM, Hesketh EL, Ritchie DS, Berridge MV. Leuk Res; 2008 Feb 01; 32(2):327-33. PubMed ID: 17580091 [Abstract] [Full Text] [Related]
19. Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines. Rangwala F, Williams KP, Smith GR, Thomas Z, Allensworth JL, Lyerly HK, Diehl AM, Morse MA, Devi GR. BMC Cancer; 2012 Sep 10; 12():402. PubMed ID: 22963400 [Abstract] [Full Text] [Related]
20. Metformin sensitizes hepatocellular carcinoma to arsenic trioxide-induced apoptosis by downregulating Bcl2 expression. Yang X, Sun D, Tian Y, Ling S, Wang L. Tumour Biol; 2015 Apr 10; 36(4):2957-64. PubMed ID: 25492486 [Abstract] [Full Text] [Related] Page: [Next] [New Search]